Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer’s disease (AD), but its role in the brain was unknown until now. In a paper ...

New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.

Tim-3, a molecule involved in immune regulation, hinders plaque removal in Alzheimer’s disease. Blocking it in microglia improved brain health in mice, making it a potential treatment target. Tim-3 is ...

I – Dr. Walensky – was chief of the Division of Infectious Diseases at Massachusetts General Hospital. When COVID-19 hit our hospitals, we were in desperate need of more infectious disease expertise.

More than 55 million people worldwide have dementia, a number expected to nearly triple by 2050. Deaths from strokes may ...

The day before the symposium, the public was invited to experience a hands-on demonstration of a surgical robot at St. Peter’s Hospital ... such as Mass General Brigham in Massachusetts ...

O ver the last few years, there has been increasing pressure on the U.S. health care system: this includes issues related to ...

We have access to pristine medical facilities, with all of the medicine in the world, and the very last hospital in Gaza is ...

The call to action from employees of the health system comes as Harvard University announced it would not be complying with ...

The new 300-bed tower, built in partnership with Beth Israel Deaconess Medical Center, would reshape the delivery of cancer ...

Mass General Brigham CEO Anne Klibanski responded to funding threats against its hospitals in an email to employees on Monday ...

Over 20 people attended a Tuesday gathering to call for MGB to disassociate with Lockheed Martin CEO James Taiclet.